IRIS
FREDIANI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.896
NA - Nord America 15.993
AS - Asia 2.733
AF - Africa 147
SA - Sud America 65
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 16
Totale 36.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.939
GB - Regno Unito 5.269
IT - Italia 2.883
IE - Irlanda 2.862
CN - Cina 1.463
RU - Federazione Russa 1.416
SE - Svezia 1.380
UA - Ucraina 1.268
DE - Germania 981
FR - Francia 857
SG - Singapore 783
FI - Finlandia 489
CI - Costa d'Avorio 123
VN - Vietnam 115
IN - India 96
ES - Italia 92
CZ - Repubblica Ceca 88
TR - Turchia 63
NL - Olanda 57
BE - Belgio 53
CA - Canada 45
BR - Brasile 35
IR - Iran 32
PK - Pakistan 30
AU - Australia 28
HK - Hong Kong 24
PL - Polonia 23
RO - Romania 23
JP - Giappone 20
GR - Grecia 19
AT - Austria 17
PT - Portogallo 16
EU - Europa 15
ID - Indonesia 14
BG - Bulgaria 13
CH - Svizzera 13
DK - Danimarca 13
CL - Cile 11
LT - Lituania 9
LV - Lettonia 9
PH - Filippine 9
AZ - Azerbaigian 8
IL - Israele 8
SK - Slovacchia (Repubblica Slovacca) 8
AE - Emirati Arabi Uniti 6
AM - Armenia 6
BD - Bangladesh 6
EC - Ecuador 6
EE - Estonia 6
MA - Marocco 6
MK - Macedonia 6
NZ - Nuova Zelanda 6
EG - Egitto 5
HU - Ungheria 5
KR - Corea 5
SA - Arabia Saudita 5
AR - Argentina 4
CY - Cipro 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LK - Sri Lanka 4
PE - Perù 4
UZ - Uzbekistan 4
BO - Bolivia 3
DZ - Algeria 3
HR - Croazia 3
IM - Isola di Man 3
KE - Kenya 3
KG - Kirghizistan 3
NO - Norvegia 3
RS - Serbia 3
TH - Thailandia 3
ZA - Sudafrica 3
AL - Albania 2
BY - Bielorussia 2
ET - Etiopia 2
IQ - Iraq 2
JM - Giamaica 2
KH - Cambogia 2
LU - Lussemburgo 2
MX - Messico 2
MY - Malesia 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
SM - San Marino 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CO - Colombia 1
DO - Repubblica Dominicana 1
JO - Giordania 1
KW - Kuwait 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
SL - Sierra Leone 1
TM - Turkmenistan 1
TW - Taiwan 1
VE - Venezuela 1
Totale 36.884
Salva come PNG Salva come JPEG
Città #
Southend 4.898
Dublin 2.817
Fairfield 2.342
Ashburn 1.446
Chandler 1.387
Woodbridge 1.197
Jacksonville 986
Wilmington 944
Seattle 825
Houston 824
Cambridge 797
Siena 733
Menlo Park 720
Ann Arbor 651
Singapore 547
Princeton 463
Nanjing 315
Helsinki 295
Beijing 290
New York 236
San Mateo 198
Boardman 188
Milan 173
Florence 161
San Diego 151
Dearborn 130
Abidjan 123
Rome 122
Moscow 116
Dong Ket 114
Nanchang 110
Shanghai 106
Munich 101
Shenyang 79
Lancaster 74
Málaga 74
Hebei 63
Düsseldorf 59
London 58
Washington 56
Tianjin 55
Fremont 54
Jiaxing 54
Izmir 50
Los Angeles 49
Brussels 47
Olomouc 46
Guangzhou 44
Norwalk 43
Jinan 40
Kunming 40
Changsha 39
Santa Clara 39
Falls Church 37
Brno 35
San Francisco 32
Chicago 30
Naples 30
Mestre 29
Redwood City 27
Toronto 26
Turin 26
Zhengzhou 26
Bologna 25
Taizhou 22
Hangzhou 21
Livorno 21
Catania 19
Dallas 19
Venezia 19
Frankfurt am Main 18
Ningbo 18
Vienna 18
Columbus 17
Zanjan 17
Bergamo 16
Padova 16
Pisa 16
Brescia 15
Nuremberg 14
Perugia 14
Tappahannock 14
Verona 14
Bari 13
Lappeenranta 13
Sofia 13
Amsterdam 12
Bangalore 12
Cedar Knolls 12
Hyderabad 12
São Paulo 12
Venice 12
Aachen 11
Chianciano Terme 11
Fort Worth 11
Genoa 11
Greifswald 11
Hong Kong 11
Hounslow 11
Monza 11
Totale 26.419
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 496
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 272
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 256
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 247
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 245
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 241
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 232
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 214
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 211
Spasmophilia and entrapment nerve syndrome comorbidities in fibromyalgic patients: a possible neuromuscular pain generator. 203
Bone mineral density in patients with systemic sclerosis. 202
Long-term effects of neridronate on human osteoblastic cell cultures 202
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 202
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 201
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 200
Radiologists and rheumatologists on performing and reporting shoulder ultrasound: From disagreement to consensus 200
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 199
Genetic mechanisms of critical illness in COVID-19 199
Antirheumatic agents in covid-19: is IL-6 the right target? 198
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 198
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 195
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 195
Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. 192
Peripheral biomarkers' panel for severe COVID-19 patients 192
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 190
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 190
Weekly oral alendronate in mevalonate kinase deficiency 189
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 189
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 187
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 186
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 183
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 183
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 183
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 182
Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound 181
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 181
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 181
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 180
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 180
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 178
Angiogenesis in alkaptonuria 178
Extracorporeal shock wave therapy in the treatment of inferior calcaneal enthesophytosis: outcome by fan-beam dual x ray absorptiometry (DXA). 177
Ultrasound in the diagnosis of calcium pyrophosphate dihydrate deposition disease. A systematic literature review and a meta-analysis 177
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 176
Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: An ultrasonographic study 174
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 170
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 170
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 170
Working the endless puzzle of hereditary autoinflammatory disorders. 169
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 168
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 167
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 167
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 167
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 164
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 164
Efficacy of extracorporeal shock wave treatment in calcaneal enthesophytosis. 163
FRI0517 The Omeract Ultrasonographic Criteria for Elementary Lesions in Calcium Pyrophosphate Deposition Disease: Results of A Delphi Process by Ultrasound Working Group 163
SAT0315 Calcium Pyrophosphate Dihydrate Deposition Disease: A Proposal of New Ultrasonographic Criteria for CPP Identification in the Joints 163
SAT0510 Ultrasound versus Synovial Fluid Analysis for the Diagnosis of Calcium Pyrophosphate Dihydrate Deposition Disease: is IT Cppd? Ask Us! 162
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 161
SAT0530 The Useful of us in Diagnosis of Carpal Tunnel Syndrome in Diabetics: a Proposal for New Reference Values 161
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 161
Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation 159
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 159
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 159
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 158
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 158
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 155
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 154
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 154
Ultrasound of enthesopathy in rheumatic diseases 152
IL-6 blockade in the management of non-infectious uveitis 152
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 152
Extracorporeal shock wave therapy for chronic calcific tendinitis of the shoulder: single blind study 151
Biologic agents for rheumatoid arthritis: Can we hypothesize new strategies of treatment? 151
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 151
Comment on: longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica. 149
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 147
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 147
null 145
Clodronate: New directions of use 145
Heel fat pad involvement in rheumatoid arthritis and in spondyloarthropathies: an ultrasonographic study. 144
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 144
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 143
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 143
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 143
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 143
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 142
Tumour necrosis factor receptor-associated periodic syndrome(TRAPS): State of the art and future perspectives 142
Determinants of bone turnover markers in healthy premenopausal women 142
Ultrasonography before and after surgery in carpal tunnel syndrome and relationship with clinical and electrophysiological findings. A new outcome predictor? 142
Prognostic bioindicators in severe COVID-19 patients 139
Evidences for antinociceptive effect of 17-alpha-hydroxyprogesterone caproate in carpal tunnel syndrome 138
Biological treatments in Behçet's disease: beyond anti-TNF therapy 138
Effect of Clodronate Treatment on Risk of Fracture: A Systematic Review and Meta-analysis 138
FRI0475 Radiologists against rheumatologists on technical aspects of shoulder ultrasound: from the disagreement to final consensus 137
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 137
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 136
Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk 136
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 135
Totale 17.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.865 0 0 0 0 356 551 533 771 560 551 189 354
2020/20215.719 306 499 236 546 375 826 236 798 491 503 400 503
2021/20224.504 384 538 307 350 262 177 196 202 273 462 477 876
2022/20235.463 365 434 687 726 439 1.083 253 442 509 152 221 152
2023/20245.248 208 158 482 288 258 1.285 1.571 198 48 137 162 453
2024/20254.044 546 779 1.633 788 298 0 0 0 0 0 0 0
Totale 38.150